Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blue and Near-Infrared light tested as a way to boost circulation

NCT ID NCT07338695

Knowledge-focused Sponsor: Afeka, The Tel-Aviv Academic College of Engineering Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether shining blue or near-infrared light on the hands can change blood flow in tiny blood vessels. Forty healthy adults will each attend two sessions, one for each light type. Researchers will use special cameras and laser devices to measure blood flow and skin temperature before, during, and after the light treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Photobiomodulation (blue and near-infrared light)
What this could lead to
If it works, this could point toward a non-invasive way to improve blood flow in conditions like Raynaud's or poor circulation.
What could go wrong
This is a very early, small study in healthy people, not patients. It only looks at immediate effects, not long-term benefits or safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Healthy males and females, between 20 and 75 years of age. 2. Willing to sign informed consent. 3. Willing to participate in two separate sessions, one for each wavelength. 4. Able to avoid caffeine and alcohol for at least 3 hours before each session. 5. Able to sit comfortably with both hands at heart level for the full measurement duration. Exclusion Criteria: 1. Currently smoking 2. Any abnormal skin condition in the area of light irradiation. 3. Pregnant, having given birth less than 3 months ago, and/or breastfeeding. 4. History of photosensitive conditions or use of photosensitizing medications 5. Suffering from significant concurrent illness, such as cardiac disorders or pertinent neurological disorders. 6. As per the Investigator's discretion, any physical or mental condition that might make it unsafe for the subject to participate in this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Microcirculation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Microcirculation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Afeka, Tel-Aviv Academic College of Engineering

    Tel Aviv, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.